VYOME HOLDINGS, INC. Proceeds from Sale of Productive Assets
VYOME HOLDINGS, INC. (HIND) reported Proceeds from Sale of Productive Assets of $33.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-04.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2025-04-04
- VYOME HOLDINGS, INC. proceeds from sale of productive assets for the quarter ending 2023-12-31 was $0.00.
- VYOME HOLDINGS, INC. proceeds from sale of productive assets for the quarter ending 2023-09-30 was $0.00.
- VYOME HOLDINGS, INC. proceeds from sale of productive assets for the quarter ending 2022-12-31 was $0.00.
- VYOME HOLDINGS, INC. proceeds from sale of productive assets for the quarter ending 2022-09-30 was $0.00.
- VYOME HOLDINGS, INC. proceeds from sale of productive assets for fiscal 2023 was $33.00K, a 15.38% decline from fiscal 2022.
- VYOME HOLDINGS, INC. proceeds from sale of productive assets for fiscal 2022 was $39.00K.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04 | $0.00 derived: sum of 2 quarters · filed 2025-04-04 | $33.00K 10-K · filed 2025-04-04 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $33.00K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $33.00K 10-Q · filed 2024-08-14 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $30.00K derived: sum of 3 quarters · filed 2024-04-01 | $39.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $30.00K derived: sum of 2 quarters · filed 2023-11-09 | $39.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $39.00K 10-Q · filed 2023-08-07 | ||
| 2022-03-31 | $9.00K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |